MedVi vs Gala: Semaglutide cost, options, and care compared
MedVi vs Gala: quick verdict up front. If you want a low promotional first month and 24/7 certified medical support, MedVi is the clearer fit. If you want access to both semaglutide and tirzepatide with a stated flat price model and included provider visits, Gala is the clearer fit.
See MedVi promotional pricing and sign up
MedVi vs Gala: five areas to compare
This comparison focuses on the most distinctive differences supported by the sources: starting price and promotional structure, medication options, clinical support and check ins, shipping and membership terms, and regulatory notes about compounded medications. Each section compares MedVi and Gala directly using only the supplied facts.
1. Starting price and pricing model
MedVi advertises a winter promotional first-month price of $179 including fast, free shipping, then states a $299 standalone month afterwards and a three-month plan at $649. Gala advertises a promotion such as $220 off and a flat all-inclusive price covering provider visit, medication, shipping and ongoing care, but the base dollar price was not exposed in readable page text. In short, MedVi shows a clear promotional entry price plus higher ongoing rates. Gala emphasizes a single flat price at every dose and a promotion but does not show the base monthly dollar amount on the captured page.
Check Gala eligibility and promotional offer
2. Medication options
MedVi provides compounded semaglutide only, with clinically dosed compounded semaglutide offered through an online program. Gala offers compounded semaglutide and tirzepatide. If access to tirzepatide is important, the evidence shows Gala includes that option while MedVi does not.
3. Clinical support and monitoring
MedVi highlights a simple online process with no clinic visits and 24/7 support from certified medical professionals. Gala provides provider check-ins and dose monitoring included, with the provider visit and prescription included in its flat-price package. Both platforms operate via direct-pay telehealth and include clinician review and prescription where medically appropriate, but MedVi emphasizes around-the-clock certified support and Gala emphasizes scheduled provider check-ins with included visits.
4. Shipping, membership, and cancellation terms
MedVi states fast, free shipping for the first-month promotional price and says no membership or hidden fees; it also shows a three-month plan option. Gala advertises free two-day shipping, no monthly membership, and cancel anytime language. Both stress no insurance is needed for direct-pay compounded medication, and Gala specifically lists no monthly membership and cancel anytime in the captured content.
5. Regulatory and safety notes
Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi includes additional notes that compounded GLP-1s are produced in FDA-regulated facilities but the medications themselves are not FDA-approved, that prescriptions are at the discretion of clinicians, and that results vary and may be influenced by diet, exercise, clinician recommendations, and adherence. Gala repeats the regulatory note and includes patient testimonial-style weight-loss examples as captured marketing content.
Comparison table at a glance
| Criteria | MedVi | Gala |
|---|---|---|
| Starting price | $179 first month promo; $299 standalone month; 3-month plan $649 | $220 promotion noted; base price not exposed in captured text |
| Medication options | Compounded semaglutide only | Compounded semaglutide and tirzepatide |
| Clinical support | 24/7 certified medical support; online clinician review | Provider visit and prescription included; provider check-ins and dose monitoring |
| Shipping and membership | Fast, free shipping; no membership or hidden fees stated | Free two-day shipping; no monthly membership; cancel anytime |
| Regulatory note | Compounded meds not FDA-approved; clinician discretion applies | Compounded meds not FDA-approved; clinician discretion applies |
How enrollment and prescriptions work
Both MedVi and Gala operate as direct-pay telehealth platforms. MedVi uses an online intake and clinician review with prescriptions filled at licensed pharmacies and shipped to your door, subject to clinician determination of eligibility. Gala states the provider visit and prescription are included and that treatment is available only when a licensed clinician determines it is medically appropriate. Both emphasize no insurance is needed for the direct-pay pathway for compounded medications.
Start MedVi intake and clinician review
Limitations of the available evidence
The captured content shows promotional claims, pricing snapshots, and customer-reported outcomes for each provider. Gala’s captured page did not expose a readable base monthly price, and marketing testimonials are presented as provider marketing. MedVi provides more explicit pricing tiers and program details in the captured evidence. Both sources include the caution that compounded medications are not FDA-approved and that prescriptions are subject to clinician review.
Review Gala plan details and eligibility
Conclusion: Choose based on price, options, and support
MedVi vs Gala comes down to three main choices: if a low promotional first month and 24/7 certified medical support with a simple online process matter most, choose MedVi. If you need the option of tirzepatide and prefer a stated flat-price model with included provider visits and cancel anytime language, choose Gala. Remember both use compounded medications that are not FDA-approved and both require clinician review to determine eligibility.
Choose MedVi if you want a clear low promotional entry price of $179 for the first month, no clinic visits, and 24/7 certified medical support.
Choose Gala if you want access to both semaglutide and tirzepatide, a flat-price model claimed at every dose, included provider visits, and free two-day shipping.